| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Claudio Raimondi | Q82713852 |
| Christiana Ruhrberg | Q21256895 | ||
| Alessandro Fantin | Q52151166 | ||
| P2093 | author name string | James T Brash | |
| P2860 | cites work | Signal transduction by vascular endothelial growth factor receptors | Q84461284 |
| First microRNA mimic enters clinic | Q87067042 | ||
| Neuronal cell death in the inner retina and the influence of vascular endothelial growth factor inhibition in a diabetic rat model | Q87630978 | ||
| Receptor complexes for each of the Class 3 Semaphorins | Q21129485 | ||
| Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion | Q24201821 | ||
| Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms | Q24290602 | ||
| Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth | Q24293042 | ||
| Neuropilin is a receptor for the axonal chemorepellent Semaphorin III | Q24310596 | ||
| Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis | Q24318367 | ||
| Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor | Q24321564 | ||
| Neuropilin-1 signaling through p130Cas tyrosine phosphorylation is essential for growth factor-dependent migration of glioma and endothelial cells | Q24337623 | ||
| The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis | Q24339531 | ||
| The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia | Q24601205 | ||
| Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction | Q24622074 | ||
| Arteriovenous crossing patterns in branch retinal vein occlusion. The Eye Disease Case-Control Study Group. | Q51060402 | ||
| Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. | Q51804185 | ||
| Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms. | Q51843697 | ||
| A paxillin tyrosine phosphorylation switch regulates the assembly and form of cell-matrix adhesions. | Q51926838 | ||
| Separating genetic and hemodynamic defects in neuropilin 1 knockout embryos. | Q51954213 | ||
| Requirement of neuropilin 1-mediated Sema3A signals in patterning of the sympathetic nervous system. | Q52124226 | ||
| A requirement for neuropilin-1 in embryonic vessel formation. | Q52174008 | ||
| Disruption of semaphorin III/D gene causes severe abnormality in peripheral nerve projection. | Q52192538 | ||
| miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1. | Q54786000 | ||
| Emerging roles for semaphorins in neural regeneration | Q56592755 | ||
| In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo | Q57395959 | ||
| Characterization of a Bicyclic Peptide Neuropilin-1 (NP-1) Antagonist (EG3287) Reveals Importance of Vascular Endothelial Growth Factor Exon 8 for NP-1 Binding and Role of NP-1 in KDR Signaling | Q58449597 | ||
| A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours | Q59059617 | ||
| Neuropilin Signalling in Vascular Development and Pathology | Q62025002 | ||
| Fibrinogen induces endothelial cell adhesion and spreading via the release of endogenous matrix proteins and the recruitment of more than one integrin receptor | Q67655761 | ||
| Oxygen-induced retinopathy in the mouse | Q71608431 | ||
| Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells | Q73626313 | ||
| Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin | Q74093564 | ||
| Neuropilin-1 is a placenta growth factor-2 receptor | Q77126823 | ||
| Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165 | Q77749029 | ||
| Intravitreal avastin: the low cost alternative to lucentis? | Q79826266 | ||
| Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2 | Q80952270 | ||
| Soluble neuropilin targeted to the skin inhibits vascular permeability | Q81574558 | ||
| A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord | Q34572480 | ||
| Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis | Q34637615 | ||
| Effect of C-terminal sequence on competitive semaphorin binding to neuropilin-1 | Q34842279 | ||
| Semaphorin3A elevates vascular permeability and contributes to cerebral ischemia-induced brain damage | Q34983840 | ||
| Tissue-penetrating delivery of compounds and nanoparticles into tumors | Q35016106 | ||
| Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A | Q35037440 | ||
| Arteriovenous sheathotomy for branch retinal vein occlusion | Q35039664 | ||
| Regulation of vascular permeability by vascular endothelial growth factors. | Q35127972 | ||
| MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression | Q35149147 | ||
| Structure-based discovery of a small non-peptidic Neuropilins antagonist exerting in vitro and in vivo anti-tumor activity on breast cancer model. | Q35154033 | ||
| Integrin-dependent and -independent functions of astrocytic fibronectin in retinal angiogenesis. | Q35224567 | ||
| Overexpression of VEGF189 in breast cancer cells induces apoptosis via NRP1 under stress conditions. | Q35534079 | ||
| Growing and shaping the vascular tree: multiple roles for VEGF | Q35568152 | ||
| Cardiomyopathy and Worsened Ischemic Heart Failure in SM22-α Cre-Mediated Neuropilin-1 Null Mice: Dysregulation of PGC1α and Mitochondrial Homeostasis. | Q35637897 | ||
| Semaphorins in angiogenesis and tumor progression | Q35658200 | ||
| Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing | Q35765155 | ||
| Neuropilin-2 regulates α6β1 integrin in the formation of focal adhesions and signaling | Q35770239 | ||
| Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis | Q35804497 | ||
| The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress | Q35836955 | ||
| MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression. | Q35853997 | ||
| Development and pathology of the hyaloid, choroidal and retinal vasculature. | Q35959824 | ||
| Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch. | Q36018663 | ||
| Neural crest-derived SEMA3C activates endothelial NRP1 for cardiac outflow tract septation | Q36040233 | ||
| Müller Glia Are a Major Cellular Source of Survival Signals for Retinal Neurons in Diabetes | Q36104659 | ||
| miRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1. | Q36185083 | ||
| Regulation of soluble neuropilin 1, an endogenous angiogenesis inhibitor, in liver development and regeneration | Q36274124 | ||
| Molecular pathogenesis of retinal and choroidal vascular diseases | Q36296789 | ||
| The impact of Vision 2020 on global blindness | Q36320422 | ||
| Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability | Q36373069 | ||
| Vascular endothelial growth factor receptor 3 controls neural stem cell activation in mice and humans | Q36387982 | ||
| Neuropilin 1 balances β8 integrin-activated TGFβ signaling to control sprouting angiogenesis in the brain | Q36398906 | ||
| Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor | Q36478465 | ||
| The role of neuropilins in cancer | Q36491431 | ||
| An unexpected role of semaphorin3a-neuropilin-1 signaling in lymphatic vessel maturation and valve formation. | Q36609207 | ||
| VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma | Q36715908 | ||
| Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity | Q36825006 | ||
| Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization | Q36948568 | ||
| A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration | Q36961818 | ||
| Ablation of Neuropilin 1 from glioma-associated microglia and macrophages slows tumor progression | Q36962800 | ||
| Inhibition of pathological retinal neovascularization by semaphorin 3A. | Q36964256 | ||
| Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport | Q37087928 | ||
| Neuropilin-2 promotes extravasation and metastasis by interacting with endothelial α5 integrin | Q37175886 | ||
| Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology | Q37301735 | ||
| Neuropilin, you gotta let me know: should I stay or should I go? | Q37660831 | ||
| Multifaceted role of neuropilins in cancer. | Q37901066 | ||
| Diverse roles for VEGF-A in the nervous system | Q37995582 | ||
| Ocular neovascularization | Q38074872 | ||
| Review of the activation of TGF-beta in immunity | Q24635194 | ||
| Selective requirements for NRP1 ligands during neurovascular patterning | Q24657194 | ||
| Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity | Q24677555 | ||
| Emerging roles for semaphorins and VEGFs in synaptogenesis and synaptic plasticity | Q27014841 | ||
| Neuropilin 1 is essential for gastrointestinal smooth muscle contractility and motility in aged mice | Q27319508 | ||
| Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells. | Q27331901 | ||
| Cdc42 is required for cytoskeletal support of endothelial cell adhesion during blood vessel formation in mice | Q27342778 | ||
| Structural basis for ligand and heparin binding to neuropilin B domains | Q27644336 | ||
| Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex | Q27648959 | ||
| Structural Basis for Selective Vascular Endothelial Growth Factor-A (VEGF-A) Binding to Neuropilin-1 | Q27677161 | ||
| Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III | Q28114812 | ||
| Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1 | Q28139948 | ||
| Cloning and characterization of neuropilin-1-interacting protein: a PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1 | Q28140309 | ||
| Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected] | Q28140705 | ||
| Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration | Q28141795 | ||
| The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1 | Q28145820 | ||
| Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function | Q28189338 | ||
| Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain | Q28216337 | ||
| VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation | Q28240025 | ||
| Integrins regulate the association and phosphorylation of paxillin by c-Abl | Q28272078 | ||
| Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity | Q28291642 | ||
| Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins | Q28294177 | ||
| Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system | Q28506910 | ||
| Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 | Q28507115 | ||
| Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation | Q28510000 | ||
| Anti-semaphorin 3A antibodies rescue retinal ganglion cells from cell death following optic nerve axotomy | Q28567462 | ||
| Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. | Q28583917 | ||
| Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development | Q28585676 | ||
| VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm | Q28587818 | ||
| Defective gonadotropin-releasing hormone neuron migration in mice lacking SEMA3A signalling through NRP1 and NRP2: implications for the aetiology of hypogonadotropic hypogonadism | Q28589834 | ||
| The cytoplasmic domain of neuropilin 1 is dispensable for angiogenesis, but promotes the spatial separation of retinal arteries and veins | Q28590445 | ||
| NRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesis | Q28592186 | ||
| Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice | Q28594495 | ||
| Neuropilin-1 expression by endothelial cells and retinal pigment epithelial cells in choroidal neovascular membranes. | Q45931412 | ||
| Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. | Q45934563 | ||
| Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). | Q46102122 | ||
| Anti-neuropilin-1 (MNRP1685A): unexpected pharmacokinetic differences across species, from preclinical models to humans | Q46211189 | ||
| Pathophysiological consequences of VEGF-induced vascular permeability | Q46349878 | ||
| Expression and mapping of duplicate neuropilin-1 and neuropilin-2 genes in developing zebrafish | Q47073354 | ||
| Cdc42 mediates Bmp-induced sprouting angiogenesis through Fmnl3-driven assembly of endothelial filopodia in zebrafish. | Q47074233 | ||
| Cloning and embryonic expression of zebrafish neuropilin genes | Q47380985 | ||
| Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability. | Q47790199 | ||
| Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice | Q48042097 | ||
| MicroRNA-30b promotes axon outgrowth of retinal ganglion cells by inhibiting Semaphorin3A expression | Q48271539 | ||
| The mouse hindbrain: an in vivo model to analyze developmental angiogenesis. | Q48425947 | ||
| Neuropilin-1 biases dendrite polarization in the retina. | Q50740559 | ||
| Microglia and interleukin-1β in ischemic retinopathy elicit microvascular degeneration through neuronal semaphorin-3A. | Q50908236 | ||
| Semaphorins and their receptors in vertebrates and invertebrates | Q28611465 | ||
| Molecular basis of semaphorin-mediated axon guidance | Q28611466 | ||
| VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding | Q28646414 | ||
| Mammalian Rho GTPases: new insights into their functions from in vivo studies | Q29615191 | ||
| VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia | Q29617501 | ||
| Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid | Q29617640 | ||
| VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. | Q30423029 | ||
| Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment | Q30450729 | ||
| The mouse retina as an angiogenesis model | Q30495106 | ||
| Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction | Q30496577 | ||
| Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis | Q30542079 | ||
| The embryonic mouse hindbrain as a qualitative and quantitative model for studying the molecular and cellular mechanisms of angiogenesis | Q30544122 | ||
| Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells | Q30579734 | ||
| A Rac/Cdc42 exchange factor complex promotes formation of lateral filopodia and blood vessel lumen morphogenesis | Q30658198 | ||
| Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis | Q30854194 | ||
| EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV. | Q33237979 | ||
| Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library | Q33267957 | ||
| Development of a new mouse model of branch retinal vein occlusion and retinal neovascularization | Q33292156 | ||
| Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors | Q33382103 | ||
| A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors | Q33413739 | ||
| A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors | Q33413979 | ||
| C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration | Q33508760 | ||
| Alphav beta3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis | Q33553383 | ||
| Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. | Q33616451 | ||
| Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation | Q33805314 | ||
| Semaphorin 3A is a chemoattractant for cortical apical dendrites. | Q33898194 | ||
| Plexina1 autoinhibition by the plexin sema domain. | Q33937108 | ||
| Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes | Q33940345 | ||
| Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish | Q34074705 | ||
| The Promise of MicroRNA Replacement Therapy | Q34134295 | ||
| Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta | Q34211886 | ||
| Polycyclic peptide therapeutics | Q34324717 | ||
| Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding | Q34340832 | ||
| A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis | Q34429094 | ||
| Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition | Q34474189 | ||
| Neurovascular development and links to disease. | Q38087874 | ||
| microRNA therapeutics in cardiovascular disease models. | Q38151144 | ||
| Neuropilin 1: function and therapeutic potential in cancer | Q38165001 | ||
| The role of neuropilin-1/semaphorin 3A signaling in lymphatic vessel development and maturation | Q38166269 | ||
| Neuropilin regulation of angiogenesis, arteriogenesis, and vascular permeability | Q38187496 | ||
| Neuropilin regulation of angiogenesis | Q38268456 | ||
| VEGF189 binds NRP1 and is sufficient for VEGF/NRP1-dependent neuronal patterning in the developing brain | Q38302151 | ||
| Semaphorin 3A is required for guidance of olfactory axons in mice. | Q38307681 | ||
| Functional interaction of VEGF-C and VEGF-D with neuropilin receptors | Q38311836 | ||
| Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain | Q38360579 | ||
| Angiogenesis versus arteriogenesis: neuropilin 1 modulation of VEGF signaling | Q38450860 | ||
| Neuropilin-1 as Therapeutic Target for Malignant Melanoma. | Q38532037 | ||
| Neurons limit angiogenesis by titrating VEGF in retina | Q39095107 | ||
| Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta | Q39615518 | ||
| Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway | Q39819576 | ||
| Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials | Q39830867 | ||
| NRP1 Regulates CDC42 Activation to Promote Filopodia Formation in Endothelial Tip Cells. | Q40036220 | ||
| Neuropilin-1 interacts with integrin beta1 and modulates pancreatic cancer cell growth, survival and invasion | Q40088181 | ||
| The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. | Q40241912 | ||
| Discovery of protein-protein binding disruptors using multi-component condensations small molecules | Q40269487 | ||
| Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration | Q40290704 | ||
| Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412. | Q40442570 | ||
| Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. | Q40461268 | ||
| Identification of two novel alternatively spliced Neuropilin-1 isoforms | Q40490511 | ||
| Furin processing of semaphorin 3F determines its anti-angiogenic activity by regulating direct binding and competition for neuropilin | Q40492075 | ||
| VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression | Q40497297 | ||
| VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis | Q40713163 | ||
| Determination of cell adhesion sites of neuropilin-1. | Q40892811 | ||
| Neuropilin-2 contributes to LPS-induced corneal inflammatory lymphangiogenesis | Q40937810 | ||
| Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse | Q40987727 | ||
| Expression of a Cell Adhesion Molecule, Neuropilin, in the Developing Chick Nervous System | Q41331048 | ||
| Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms | Q41588972 | ||
| Steering clear of semaphorins: neuropilins sound the retreat | Q41680101 | ||
| Anatomy of arteriovenous crossings in branch retinal vein occlusion | Q41856281 | ||
| Elevated vascular endothelial growth factor receptor-2 abundance contributes to increased angiogenesis in vascular endothelial growth factor receptor-1-deficient mice | Q41937678 | ||
| Transmembrane domain interactions control biological functions of neuropilin-1 | Q41943261 | ||
| Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas | Q42015184 | ||
| Neuropilin-1 regulates platelet-derived growth factor receptor signalling in mesenchymal stem cells | Q42243380 | ||
| Specific cell surface labels in the visual centers of Xenopus laevis tadpole identified using monoclonal antibodies | Q42516876 | ||
| Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation | Q42798551 | ||
| Sema-3A indirectly disrupts the regeneration process of goldfish optic nerve after controlled injury | Q43070415 | ||
| Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk. | Q43171711 | ||
| Sequence dependence of C-end rule peptides in binding and activation of neuropilin-1 receptor | Q43604816 | ||
| Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. | Q43871279 | ||
| VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma | Q44068637 | ||
| Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling | Q44612704 | ||
| Anti-chemorepulsive effects of vascular endothelial growth factor and placental growth factor-2 in dorsal root ganglion neurons are mediated via neuropilin-1 and cyclooxygenase-derived prostanoid production | Q44883177 | ||
| Pharmacokinetic and pharmacodynamic analysis of circulating biomarkers of anti-NRP1, a novel antiangiogenesis agent, in two phase I trials in patients with advanced solid tumors | Q44946305 | ||
| Zebrafish neuropilins are differentially expressed and interact with vascular endothelial growth factor during embryonic vascular development | Q45014361 | ||
| Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1. | Q45264074 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | membrane protein | Q423042 |
| neovascularization | Q1281049 | ||
| cell surface receptor | Q2476074 | ||
| eye disease | Q3041498 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 64-83 | |
| P577 | publication date | 2016-02-27 | |
| 2016-05-01 | |||
| P1433 | published in | Progress in Retinal and Eye Research | Q15760062 |
| P1476 | title | NRP1 function and targeting in neurovascular development and eye disease | |
| P478 | volume | 52 |
| Q64965484 | Alternative Splicing in Angiogenesis. |
| Q49787990 | Endothelial Cell Metabolism. |
| Q36123798 | NRP-1 Receptor Expression Mismatch in Skin of Subjects with Experimental and Diabetic Small Fiber Neuropathy |
| Q91606297 | Neuron-derived VEGF contributes to cortical and hippocampal development independently of VEGFR1/2-mediated neurotrophism |
| Q41503921 | Neuropilin 1 sequestration by neuropathogenic mutant glycyl-tRNA synthetase is permissive to vascular homeostasis |
| Q60960382 | Neuropilin-1 Controls Endothelial Homeostasis by Regulating Mitochondrial Function and Iron-Dependent Oxidative Stress |
| Q52726394 | Neuropilin-1and platelet-derived growth factor receptors cooperatively regulate intermediate filaments and mesenchymal cell migration during alveolar septation. |
| Q92889765 | Oxygen-induced circRNA profiles and coregulatory networks in a retinopathy of prematurity mouse model |
| Q47326758 | Potentiating angiogenesis arrest in vivo via laser irradiation of peptide functionalised gold nanoparticles. |
| Q89849549 | Role of Smad4 from ocular surface ectoderm in retinal vasculature development |
| Q52724942 | Sustained Release of Endothelial Progenitor Cell-Derived Extracellular Vesicles from Shear-Thinning Hydrogels Improves Angiogenesis and Promotes Function after Myocardial Infarction. |
| Q89910217 | The functions and applications of A7R in anti-angiogenic therapy, imaging and drug delivery systems |
| Q42370368 | The potential of anti-VEGF (Vasotide) by eye drops to treat proliferative retinopathies. |
| Q42292864 | VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation. |
Search more.